Kevin Lei
Associate Director, Business Development
Kevin brings a diverse set of experience in biopharma and techbio business development, as well as tech transfer in early-stage companies. Prior to joining BigHat, he focused on business development transactions in oncology in-licensing at Exelixis. Kevin has also worked on sell-side business development at multiple AI-driven drug discovery companies. He earned his PhD in Immunology from the University of Chicago and holds a B.A. in Molecule and Cell Biology from the University of California, Berkeley.
